Skip to main content

Advertisement

Log in

Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent

  • Letter to the Editors
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Jaguszewski M, Ghadri JR, Zipponi M, Bataiosu DR, Diekmann J, Geyer V, Neumann CA, Huber MA, Hagl C, Erne P, Luscher TF, Templin C (2015) Feasibility of second-generation bioresorbable vascular scaffold implantation in complex anatomical and clinical scenarios. Clin Res Cardiol 104(2):124–135. doi:10.1007/s00392-014-0757-4

    Article  CAS  PubMed  Google Scholar 

  2. Schinke K, Langwieser N, Laugwitz KL, Ibrahim T (2015) A potential life-threatening complication after implantation of a bioresorbable scaffold for coronary stenting within a mechanically stressed region. Clin Res Cardiol 104(4):366–367. doi:10.1007/s00392-014-0808-x

    Article  PubMed  Google Scholar 

  3. Gil RJ, Bil J, Pawlowski T, Yuldashev N, Kolakowski L, Janczak J, Jablonski W, Palinski P (2016) The use of bioresorbable vascular scaffold Absorb BVS(R) in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment. Kardiol Pol 74(7):627–633. doi:10.5603/KP.a2015.0250

    Article  PubMed  Google Scholar 

  4. Trobs M, Achenbach S, Rother J, Klinghammer L, Schlundt C (2016) Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Catheter Cardiovasc Interv. doi:10.1002/ccd.26569

    PubMed  Google Scholar 

  5. Raber L, Brugaletta S, Yamaji K, O’Sullivan CJ, Otsuki S, Koppara T, Taniwaki M, Onuma Y, Freixa X, Eberli FR, Serruys PW, Joner M, Sabate M, Windecker S (2015) Very Late Scaffold Thrombosis: Intracoronary Imaging and Histopathological and Spectroscopic Findings. J Am Coll Cardiol 66(17):1901–1914. doi:10.1016/j.jacc.2015.08.853

    Article  CAS  PubMed  Google Scholar 

  6. Braun D, Baquet M, Massberg S, Mehilli J, Hausleiter J (2016) Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold. JACC Cardiovasc Interv 9 (1):e13–14. doi:10.1016/j.jcin.2015.10.019

    Article  PubMed  Google Scholar 

  7. Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrie D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iniguez A, Sabate M, Windecker S, Onuma Y (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479–2491. doi:10.1016/S0140-6736(16)32050-5

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David M. Leistner.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states the following conflicts of interest: C.S. is principal investigator within the DEsolve I trial (NCT02086006); V.S.S., U.L., M.R., Y.S.A. and D.M.L. have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schneider, V.S., Skurk, C., Riedel, M. et al. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent. Clin Res Cardiol 106, 557–559 (2017). https://doi.org/10.1007/s00392-017-1091-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-017-1091-4

Keywords

Navigation